Bruker Corp [BRKR] stock is trading at $66.80, up 2.72%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The BRKR shares have gain 4.39% over the last week, with a monthly amount glided 2.64%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Bruker Corp [NASDAQ: BRKR] stock has seen the most recent analyst activity on August 28, 2024, when Wells Fargo initiated its Overweight rating and assigned the stock a price target of $78. On February 14, 2024, upgrade upgraded it’s rating to Overweight and revised its price target to $90 on the stock. Wells Fargo started tracking the stock assigning a Equal Weight rating and suggested a price target of $72 on December 19, 2023. Wolfe Research initiated its recommendation with a Outperform and recommended $80 as its price target on December 13, 2023. UBS started tracking with a Buy rating for this stock on October 21, 2022, and assigned it a price target of $70. In a note dated August 22, 2022, Citigroup upgraded an Buy rating on this stock and boosted its target price from $70 to $80.
Bruker Corp [BRKR] stock has fluctuated between $53.79 and $94.86 over the past year. Currently, Wall Street analysts expect the stock to reach $71.67 within the next 12 months. Bruker Corp [NASDAQ: BRKR] shares were valued at $66.80 at the most recent close of the market. An investor can expect a potential return of 7.29% based on the average BRKR price forecast.
Analyzing the BRKR fundamentals
Bruker Corp [NASDAQ:BRKR] reported sales of 3.12B for the trailing twelve months, which represents a growth of 17.42%. Gross Profit Margin for this corporation currently stands at 0.5% with Operating Profit Margin at 0.12%, Pretax Profit Margin comes in at 0.15%, and Net Profit Margin reading is 0.11%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.24 and Total Capital is 0.08. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 65.23 points at the first support level, and at 63.66 for the second support level. However, for the 1st resistance point, the stock is sitting at 68.10, and for the 2nd resistance point, it is at 69.40.
Ratios To Look Out For
For context, Bruker Corp’s Current Ratio is 1.65. As well, the Quick Ratio is 0.75, while the Cash Ratio is 0.13. Considering the valuation of this stock, the price to sales ratio is 3.24, the price to book ratio is 5.65 and price to earnings (TTM) ratio is 27.77.
Transactions by insiders
Recent insider trading involved ROSENTHAL BOB, Director, that happened on Aug 15 ’24 when 4684.0 shares were sold. Director, ROSENTHAL BOB completed a deal on Aug 15 ’24 to buy 4684.0 shares. Meanwhile, Director Requardt Hermann Fritz sold 15000.0 shares on Mar 04 ’24.
